Revenues expected to be slightly above the consensus estimates Trefis estimates Boston Scientific's Q1 2022 revenues to be around $3.0 billion, slightly above the $2.9 billion consensus estimate.
Revenues expected to be slightly above the consensus estimates Trefis estimates Boston Scientific's Q1 2022 revenues to be around $3.0 billion, slightly above the $2.9 billion consensus estimate.
Share this Article
Recommended